Abstract

Non-pathogenic Neisseria are a reservoir of antimicrobial resistance genes for pathogenic Neisseria meningitidis and Neisseria gonorrhoeae. Men who have sex with men (MSM) are at risk of co-colonization with resistant non-pathogenic and pathogenic Neisseria. We assessed if the antimicrobial susceptibility of non-pathogenic Neisseria among MSM differs from a general population and if antimicrobial exposure impacts susceptibility. We recruited 96 participants at our center in Belgium: 32 employees, 32 MSM who did not use antibiotics in the previous 6 months, and 32 MSM who did. Oropharyngeal Neisseria were cultured and identified with MALDI-TOF–MS. Minimum inhibitory concentrations for azithromycin, ceftriaxone and ciprofloxacin were determined using E-tests® and compared between groups with non-parametric tests. Non-pathogenic Neisseria from employees as well as MSM were remarkably resistant. Those from MSM were significantly less susceptible than employees to azithromycin and ciprofloxacin (p < 0.0001, p < 0.001), but not ceftriaxone (p = 0.3). Susceptibility did not differ significantly according to recent antimicrobial exposure in MSM. Surveilling antimicrobial susceptibility of non-pathogenic Neisseria may be a sensitive way to assess impact of antimicrobial exposure in a population. The high levels of antimicrobial resistance in this survey indicate that novel resistance determinants may be readily available for future transfer from non-pathogenic to pathogenic Neisseria.

Details

Title
Antimicrobial susceptibility of commensal Neisseria in a general population and men who have sex with men in Belgium
Author
Laumen Jolein Gyonne Elise 1 ; Christophe, Van Dijck 1 ; Abdellati Saïd 2 ; De Baetselier Irith 2 ; Serrano, Gabriela 3 ; Manoharan-Basil, Sheeba Santhini 2 ; Bottieau Emmanuel 2 ; Martiny Delphine 4 ; Kenyon, Chris 5   VIAFID ORCID Logo 

 Institute of Tropical Medicine Antwerp, Department of Clinical Sciences, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088); University of Antwerp, Laboratory of Medical Microbiology, Wilrijk, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681) 
 Institute of Tropical Medicine Antwerp, Department of Clinical Sciences, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088) 
 Université Libre de Bruxelles, Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles, Pôle Hospitalier Universitaire de Bruxelles, Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746) 
 Université Libre de Bruxelles, Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles, Pôle Hospitalier Universitaire de Bruxelles, Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université de Mons, Faculté de Médecine et Pharmacie, Mons, Belgium (GRID:grid.8364.9) (ISNI:0000 0001 2184 581X) 
 Institute of Tropical Medicine Antwerp, Department of Clinical Sciences, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088); University of Cape Town, Department of Medicine, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2619581735
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.